Client News
AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement
24th January 2024
Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024
24th January 2024
BioLizard announces Swiss subsidiary and service offering for AI-powered digital transformation of life sciences at Biopôle in Lausanne
23rd January 2024
Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months
22nd January 2024
Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain
18th January 2024
Affluent Medical: Pre-submission dossier for the 510(k) of medical device Kalios filed with FDA for review
15th January 2024
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
11th January 2024
AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS® for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients
9th January 2024
InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
4th January 2024
There is no more content to load